Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ (2011) 5.84

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.27

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. Br J Gen Pract (2012) 1.46

Update on anti-coagulation in atrial fibrillation. QJM (2011) 1.28

Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. Am J Med (2012) 1.13

CHADS₂ score: its predictive capacity in clinical practice. Arq Bras Cardiol (2013) 1.07

Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev (2010) 1.04

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J (2013) 1.03

Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation. Chest (2011) 0.98

Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial. BMJ (2011) 0.90

Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scores. Am J Cardiovasc Dis (2012) 0.88

Heart failure and atrial fibrillation: from basic science to clinical practice. Int J Mol Sci (2015) 0.87

Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation. Heart Vessels (2010) 0.85

Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents. Europace (2012) 0.84

Stroke in younger patients: the heart of the matter. J Neurol (2010) 0.84

Challenges in the classification of atrial fibrillation. Nat Rev Cardiol (2010) 0.83

Prolonged atrial fibrillation following generalized tonic-clonic seizures. Seizure (2012) 0.82

Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thromb Res (2010) 0.82

Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach. Aging Dis (2012) 0.82

Left atrial appendage exclusion-Where do we stand? J Thorac Dis (2014) 0.80

Transesophageal echocardiographic findings are independent and relevant predictors of ischemic stroke in patients with nonvalvular atrial fibrillation. J Clin Neurol (2012) 0.80

Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J (2009) 0.79

Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study. PLoS One (2016) 0.78

Intensity of Left Atrial Spontaneous Echo Contrast as a Correlate for Stroke Risk Stratification in Patients with Nonvalvular Atrial Fibrillation. Sci Rep (2016) 0.75

Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients. Interact Cardiovasc Thorac Surg (2013) 0.75

Stroke Prevention in Atrial Fibrillation. J Atr Fibrillation (2010) 0.75

The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis. Popul Health Manag (2014) 0.75

Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc (2016) 0.75